Form 4 · ABBV
AbbVie EVP Azita Saleki reports exercising or converting 23,935 shares
Part of a grouped insider digest: see all related filings with totals →
Azita Saleki, AbbVie's EVP, CHIEF OPERATIONS OFFICER, filed a Form 4 on Nov 18, 2026 at 5:00 PM ET reporting transactions on Nov 16, 2026.
The filing reports 23,935 shares in an exercise or conversion of a derivative security (code M); and 13,481 shares withheld to pay the exercise price or tax (code F).
After these transactions, the filing lists 208,248 shares of Common Stock, $0.01 par value held directly.
Effect on holdings
Taken together, the rows reported here raised Azita Saleki's directly held shares by 5.3%, from 197,794 to 208,248.
Reporting person
- Azita Saleki, EVP, CHIEF OPERATIONS OFFICER (as filed: SALEKI AZITA)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-16 | M | Common Stock, $0.01 par value | 23,935 | $61.36 | Acquired | 221,729 | Direct |
| 2026-11-16 | F | Common Stock, $0.01 par value | 13,481 | $298.55 | Disposed | 208,248 | Direct |
| 2026-11-16 | M | Option (Right to Buy) (derivative) | 13,481 | Disposed | 23,935 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 18, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
AbbVie company file → · More AbbVie filings
The filings digest
A free email of market-moving SEC filings. Daily on weekdays, or one weekly edition.
Disclosures
- Editor holdings in ABBV
- The editor holds no position in AbbVie (ABBV). As of Nov 11, 2026.
- Last updated
- Nov 18, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold ABBV.